According to BRAIN Biotech's latest financial reports the company has A$18.17 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-09-30 | A$8.9 M | -32.99% |
2022-09-30 | A$13.28 M | -66.64% |
2021-09-30 | A$39.83 M | 27.23% |
2020-09-30 | A$31.3 M | 27.06% |
2019-09-30 | A$24.63 M | -40.28% |
2018-09-30 | A$41.25 M | -29.83% |
2017-09-30 | A$58.78 M | 116.47% |
2016-09-30 | A$27.15 M | 385.61% |
2015-09-30 | A$5.59 M |